Article info
Original article
Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
- Correspondence to Dr Philip J Ferrone, Long Island Vitreoretinal Consultants, 600 Northern Boulevard, Suite 216, Great Neck, NY 11021, Columbia University New York, NY, USA; p_ferrone{at}hotmail.com
Citation
Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
Publication history
- Received October 17, 2013
- Revised March 27, 2014
- Accepted March 29, 2014
- First published May 2, 2014.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/